Schneeweiss S - Search Results

1

Accuracy of identifying neutropenia diagnoses in outpatient claims data.

Kim SY, Solomon DH, Liu J, Chang CL, Daniel GW, Schneeweiss S. Kim SY, et al. Among authors: schneeweiss s. Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):709-13. doi: 10.1002/pds.2157. Epub 2011 May 12. Pharmacoepidemiol Drug Saf. 2011. PMID: 21567653 Free PMC article.

2

Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?

Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J. Solomon DH, et al. Among authors: schneeweiss s. Am J Med. 2003 Dec 15;115(9):715-20. doi: 10.1016/j.amjmed.2003.08.025. Am J Med. 2003. PMID: 14693324

3

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.

Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Solomon DH, et al. Among authors: schneeweiss s. Circulation. 2004 May 4;109(17):2068-73. doi: 10.1161/01.CIR.0000127578.21885.3E. Epub 2004 Apr 19. Circulation. 2004. PMID: 15096449

4

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.

Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Kiyota Y, et al. Among authors: schneeweiss s. Am Heart J. 2004 Jul;148(1):99-104. doi: 10.1016/j.ahj.2004.02.013. Am Heart J. 2004. PMID: 15215798

5

Relationship between COX-2 specific inhibitors and hypertension.

Solomon DH, Schneeweiss S, Levin R, Avorn J. Solomon DH, et al. Among authors: schneeweiss s. Hypertension. 2004 Aug;44(2):140-5. doi: 10.1161/01.HYP.0000136134.31846.83. Epub 2004 Jun 28. Hypertension. 2004. PMID: 15226279

6

Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors.

Jacobus S, Schneeweiss S, Chan KA. Jacobus S, et al. Among authors: schneeweiss s. Pharmacoepidemiol Drug Saf. 2004 Oct;13(10):695-702. doi: 10.1002/pds.981. Pharmacoepidemiol Drug Saf. 2004. PMID: 15386727

7

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.

Fischer MA, Schneeweiss S, Avorn J, Solomon DH. Fischer MA, et al. Among authors: schneeweiss s. N Engl J Med. 2004 Nov 18;351(21):2187-94. doi: 10.1056/NEJMsa042770. N Engl J Med. 2004. PMID: 15548779 Free article.

8

Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction.

Schneeweiss S, Glynn RJ, Tsai EH, Avorn J, Solomon DH. Schneeweiss S, et al. Epidemiology. 2005 Jan;16(1):17-24. doi: 10.1097/01.ede.0000147164.11879.b5. Epidemiology. 2005. PMID: 15613941

9

A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.

Schneeweiss S, Glynn RJ, Avorn J, Solomon DH. Schneeweiss S, et al. J Clin Epidemiol. 2005 Jan;58(1):98-102. doi: 10.1016/j.jclinepi.2004.06.002. J Clin Epidemiol. 2005. PMID: 15649677

10

Identification of individuals with CKD from Medicare claims data: a validation study.

Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH. Winkelmayer WC, et al. Among authors: schneeweiss s. Am J Kidney Dis. 2005 Aug;46(2):225-32. doi: 10.1053/j.ajkd.2005.04.029. Am J Kidney Dis. 2005. PMID: 16112040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

630 results

Search Page

Filters